The following articles (labelled with PubMed ID or TBD) are for your review
PMID | Data | Article Title | Organization |
9554878 |
35 |
Nonpeptide cyclic cyanoguanidines as HIV-1 protease inhibitors: synthesis, structure-activity relationships, and X-ray crystal structure studies. |
Dupont Pharmaceuticals |
9089336 |
77 |
Structure-based design of nonpeptidic HIV protease inhibitors: the sulfonamide-substituted cyclooctylpyramones. |
Upjohn |
1910089 |
30 |
Design and synthesis of HIV protease inhibitors. Variations of the carboxy terminus of the HIV protease inhibitor L-682,679. |
Merck Sharp and Dohme Research Laboratories |
9888839 |
140 |
Stereospecific synthesis, structure-activity relationship, and oral bioavailability of tetrahydropyrimidin-2-one HIV protease inhibitors. |
Dupont Pharmaceuticals |
9171880 |
21 |
Design, synthesis, and evaluation of tetrahydropyrimidinones as an example of a general approach to nonpeptide HIV protease inhibitors. |
Dupont Pharmaceuticals |
9719600 |
21 |
Tipranavir (PNU-140690): a potent, orally bioavailable nonpeptidic HIV protease inhibitor of the 5,6-dihydro-4-hydroxy-2-pyrone sulfonamide class. |
Upjohn |
8893827 |
17 |
Structure-based design of HIV protease inhibitors: sulfonamide-containing 5,6-dihydro-4-hydroxy-2-pyrones as non-peptidic inhibitors. |
Upjohn |